86209-35-0 Usage
Uses
Used in Pharmaceutical Industry:
6-Chloro-2-Hydroxy-quinoline-3-carboxylic acid is used as a building block for the synthesis of new drugs due to its bioactive structure and unique chemical characteristics. Its presence in the family of Quinolines, which are known for their medicinal properties, suggests that 6-CHLORO-2-HYDROXY-QUINOLINE-3-CARBOXYLIC ACID may play a significant role in the development of novel therapeutic agents.
Used in Medicinal Chemistry Research:
6-Chloro-2-Hydroxy-quinoline-3-carboxylic acid is used as a research compound for exploring its potential biological activities and interactions with biological targets. The presence of the chlorine atom, hydroxy group, and carboxylic acid group may allow for the modulation of its chemical reactivity and binding affinity, making it an interesting subject for studies aimed at understanding its potential applications in drug discovery and design.
Used in Drug Design and Development:
6-Chloro-2-Hydroxy-quinoline-3-carboxylic acid is used as a starting material for the design of new drugs, particularly in the field of medicinal chemistry. Its unique chemical features may enable the creation of drugs with improved efficacy, selectivity, and reduced side effects, contributing to the advancement of pharmaceutical treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 86209-35-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,2,0 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 86209-35:
(7*8)+(6*6)+(5*2)+(4*0)+(3*9)+(2*3)+(1*5)=140
140 % 10 = 0
So 86209-35-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H6ClNO3/c11-6-1-2-8-5(3-6)4-7(10(14)15)9(13)12-8/h1-4H,(H,12,13)(H,14,15)
86209-35-0Relevant academic research and scientific papers
HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER
-
, (2020/10/20)
Compounds which are thiazole and triazole derivatives are disclosed, including compounds of the following genus: Formula I. The compounds are inhibitors of hematopoietic cell kinase (HCK) and exhibit anti-fibrotic and anti-proliferative effects. They are useful in the treatment of a variety of disorders, including a fibrosis or a fibrotic disease, such as renal fibrosis.
GLYCINE B ANTAGONISTS
-
Page/Page column 47, (2010/04/27)
The invention relates to quinoline derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
